John Craig Thompson insider trades

Open-market stock purchases and sales by John Craig Thompson, Director at Esperion Therapeutics, Inc, from SEC Form 4 filings since Jan 10, 2011.

Recent trades

DateStockTradeValue
May 28, 2026ESPR Esperion Therapeutics, IncBought (not open market)—

Companies traded

  • ESPR Esperion Therapeutics, Inc: other filings, last May 28, 2026
  • ANTH Anthera Pharmaceuticals Inc: 2 buys, last Jan 5, 2018
  • TTPH Tetraphase Pharmaceuticals Inc: 7 sales, last Sep 8, 2015
  • TSRX Trius Therapeutics Inc: 1 buy, last Sep 11, 2013

Get free alerts when John Craig Thompson files a new trade →